NASDAQ:ARNA
Delisted
Arena Pharmaceuticals Stock News
$99.99
+0 (+0%)
At Close: May 27, 2022
If You Had Bought Arena Pharmaceuticals (NASDAQ:ARNA) Shares Three Years Ago You'd Have Made 283%
12:27pm, Sunday, 19'th Apr 2020
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
3 Reasons Medical Marijuana Is a Better Long-Term Investment Than Recreational Pot
11:45am, Sunday, 19'th Apr 2020
Not all pot stocks are wildly volatile, and there are safer options out there for cannabis investors.
Arena Pharmaceuticals (NASDAQ:ARNA) Stock Rating Reaffirmed by Needham & Company LLC
09:30am, Thursday, 16'th Apr 2020
Arena Pharmaceuticals (NASDAQ:ARNA)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a research report issued on Tuesday, AnalystRatings.com repo
Needham Keeps a Buy Rating on Arena Pharma (ARNA)
08:45pm, Tuesday, 14'th Apr 2020
Needham analyst Alan Carr maintained a Buy rating on Arena Pharma (ARNA) today and set a price target of $70.00. The company's shares closed last Tuesday
Needham Keeps a Buy Rating on Arena Pharma (ARNA)
08:45pm, Tuesday, 14'th Apr 2020
Needham analyst
Alan Carr
maintained a
Buy
rating on Arena Pharma (
ARNA
–
Research Report
) today and set a price target of
$70.00
. The company’s shares closed last Tuesday at $48.83.
According
ESPAOL • Empresas de Cannabis con Acciones el NYSE y NASDAQ: Una Lista Completa
05:47pm, Tuesday, 14'th Apr 2020
Articulo via El Planteo.Mientras la industria del cannabis sigue avanzando, mas y mas compañias se mueven para conseguir que sus acciones esten en las listas de las bolsas de valores estadounidenses
Tracon Pharmaceuticals appoints Shahe Garabedian as SVP, Quality Assurance TCON;ARNA
12:51pm, Tuesday, 14'th Apr 2020
Tracon Pharmaceuticals appoints Shahe Garabedian as SVP, Quality Assurance TCON ARNA
TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development
Stocks With Rising Relative Price Strength: Arena Pharmaceuticals
12:00am, Tuesday, 14'th Apr 2020
Pulmonary Arterial Hypertension Market Research Report by Drug Class (Calcium Channel Blocker, Endothelin Receptor Antagonists, Phosphodiesterase 5, and Prostacyclin & Prostacyclin Analog), by Distrib
Bullish, Bearish, Perplexed, Doesn’t Matter — Stay In Shape
10:08pm, Sunday, 12'th Apr 2020
We’re now going through the hard part of the stock-market crash. The relentless downward momentum has eased and we’ve even seen some rallies, not to mention, indications, that the coronavirus curv
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Average Rating of "Hold" from Analysts
10:22am, Sunday, 12'th Apr 2020
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) have earned a consensus rating of “Hold” from the ten ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analy
Bullish, Bearish, Perplexed, Doesn't Matter — Stay In Shape
12:00am, Sunday, 12'th Apr 2020Cubist Systematic Strategies LLC Buys 10,957 Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
10:06am, Saturday, 11'th Apr 2020
Cubist Systematic Strategies LLC lifted its stake in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) by 5,267.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC.
